$950.000 Vergleich bei Behandlungsfehlern
2. August 2017
Kategorie: Behandlungsfehler
Ausgewählte Anwälte
Partner
Artikel aus unserem Blog
Andexanet Alfa (Andexxa) Withdrawn from U.S. Market: What Patients Need to Know
by Christopher R. LoPalo, Partner AstraZeneca has withdrawn Andexxa (andexanet alfa) from the United States market effective December 22, 2025. Patients who experienced adverse health outcomes, complications, or...
Lesen Sie den ArtikelPFAS in Biosolids: 2025 Statehouses Take the Lead
For PFAS in biosolids, 2025 was the year statehouses stepped decisively into the vacuum. While federal policy is evolving, state and local governments are rapidly redrawing the rules...
Lesen Sie den ArtikelSuspected Birth Injury? What Parents Need to Know and Do Next
Bringing a baby into the world is supposed to be joyful. When something goes wrong during pregnancy, labor, or delivery, that joy can be replaced in an instant...
Lesen Sie den Artikel